Kevin Zussman writes about the similarities of the crop protection and animal health industries, and how new technologies are disrupting these markets.
CRISPR has been lauded as the cheapest, fastest, and most precise gene-editing tool on the market, and it’s not subjected to the tainted GMO label, but for how much longer?
Monsanto’s CRISPR license comes with restrictions.
The gene-editing powerhouse the merger between Bayer and Monsanto could produce has been less discussed in media and investment circles, but is a major part of the transaction, writes Emma Cowan.
